Le Lézard
Classified in: Science and technology, Business
Subjects: SHAREHOLDER RIGHTS PLANS, CORPORATE OFFICERS

Gorilla Technology Group Announces Business Update


LONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Gorilla Technology Group Inc. ("Gorilla") (NASDAQ: GRRR), a global provider of Smart Country AI, IoT technologies, and Cybersecurity, today updated investors on operating and financial progress.

Business Highlights

Operational Highlights

"We believe we are in great shape heading into 2024, having completed several transformational initiatives and secured the largest client win in our history," stated Jay Chandan, CEO of Gorilla. "Our progress in Egypt gives us great visibility on near-term growth and is laying the foundation for expansion across global markets. We are continually innovating to the ever-evolving needs of our demanding global clientele. We have tasked ourselves to building towards a global sales pipeline of $1 billion. With a strong financial foundation, strategic initiatives and a forward-looking approach, Gorilla is well-positioned for continued success and growth in the months ahead. We remain relentless in our pursuit of excellent results for clients, employees, and shareholders."

Earnings Reporting

As a foreign private issuer under U.S. Securities and Exchange Commission (SEC) regulations, Gorilla is only required to disclose financial results annually on Form 20-F. This business update is intended to provide additional visibility into operating progress. Audited results for the full year 2023 will be announced in the first half of 2024.

About Gorilla Technology Group Inc.

"Empowering Your Tomorrow"

Gorilla, headquartered in London U.K., is a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence and IoT technology. Gorilla provides a wide range of solutions, including, Smart City, Network, Video, Security Convergence and IoT across select verticals of Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare and Education.

The Company's vision is to empower a connected tomorrow through innovative and transformative technologies. Gorilla envisions a world where seamless connectivity transcends boundaries, enriching lives, industries, and societies.

Gorilla's commitment is to lead the way in pioneering cutting-edge solutions that bridge gaps, foster collaboration and inspire progress. By relentlessly pushing the boundaries of technology, the Company aims to create an ecosystem where individuals, businesses and communities thrive in an era of digital empowerment.

Through continuous innovation, ethical practices and a steadfast dedication to quality, Gorilla strives to shape a future where every interaction, transaction, and experience is enhanced by the power of technology.

For more information, go to Gorilla-Technology.com.

Media Contact:
Jeff Fox
The Blueshirt Group for Gorilla
+1 (415) 828-8298
[email protected]

Investor Relations Contacts:
Gary Dvorchak
The Blueshirt Group for Gorilla
+1 (323) 240-5796
[email protected]

Scott McCabe
The Blueshirt Group for Gorilla
+1 (917) 434-3275
[email protected]



These press releases may also interest you

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: